Camkii Alpha Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CaMKIIα (Calcium/Calmodulin-Dependent Protein Kinase II Alpha) is one of the most abundant proteins in the brain and serves as a master regulator of synaptic plasticity. With its unique multimeric structure and ability to undergo autophosphorylation, CaMKII acts as a molecular memory device that can sustain its activity even after calcium levels return to baseline. This makes CaMKII critical for learning, memory, and long-term potentiation (LTP).
| Property |
Value |
| Protein Name |
Calcium/Calmodulin-Dependent Protein Kinase II Alpha |
| Gene Symbol |
CAMK2A |
| UniProt ID |
P9UQFG3 |
| Molecular Weight |
54.7 kDa (monomer) |
| Subcellular Location |
Postsynaptic density, dendritic spines |
| Protein Family |
CaMKII family (Ser/Thr protein kinase) |
| PDB Structures |
2BDW, 3BX4, 3KL8, 5MVL |
| Expression |
Brain-specific (neurons), highest in hippocampus and cortex |
CaMKII forms a distinctive holoenzyme structure:
- 12 subunits: Arranged in two stacked hexameric rings
- Hexameric rings: Each ring contains 6 subunits
- Dodecameric assembly: Two hexameric rings face each other
- Subunit composition: Can be α, β, γ, or δ isoforms
¶ Domain Organization
| Domain |
Position |
Function |
| N-terminal catalytic domain |
1-270 |
Kinase activity, substrate binding |
| Regulatory domain |
281-340 |
Autoinhibitory, calmodulin-binding |
| Association domain |
315-475 |
Multimerization, holoenzyme assembly |
- Autoinhibitory segment: Blocks catalytic site in basal state
- Calmodulin-binding domain: Binds calcium-calmodulin for activation
- T286 autophosphorylation site: Critical for calcium-independent activity
- Hub domain: Central association domain for multimerization
CaMKIIα exhibits region-specific expression:
- Hippocampus: Highest expression in CA1, CA3, dentate gyrus
- Cerebral cortex: Layer 2/3 and Layer 5 pyramidal neurons
- Amygdala: Principal neurons and interneurons
- Striatum: Medium spiny neurons
- Cerebellum: Purkinje cells (lower expression)
- Thalamus: Relay neurons
- Postsynaptic density (PSD): Highly enriched in dendritic spines
- Synaptic vesicles: Association with presynaptic terminals
- Nucleus: Some nuclear localization reported
- Dendritic shafts: Mobile between spine compartments
- Emerges postnatally (P7-P14 in mice)
- Expression increases during critical period of synaptogenesis
- Maintained at high levels throughout adulthood
- Declines with age in some regions
Calmodulin-Dependent Activation:
- Calcium influx through NMDA receptors or voltage-gated calcium channels
- Calcium binds calmodulin (4 Ca²⁺ per calmodulin)
- Calcium-calmodulin binds to CaMKII regulatory domain
- Autoinhibitory segment released
- Catalytic domain becomes active
- Autophosphorylation at T286 initiates
Autophosphorylation:
- T286 autophosphorylation makes activity calcium-independent
- Phosphorylated CaMKII remains active after calcium returns to baseline
- Acts as a molecular memory of prior calcium signaling
- Enables sustained synaptic modification
CaMKII phosphorylates numerous synaptic proteins:
| Substrate |
Site |
Functional Effect |
| NR2B (GluN2B) |
S1303 |
Enhanced channel activity |
| AMPA receptor GluA1 |
S831 |
Enhanced conductance |
| Synapsin I |
S566 |
Synaptic vesicle release |
| CREB |
S133 |
Gene transcription |
| MAP2 |
Multiple |
Dendritic stability |
| tau |
Multiple |
Kinase implicated in AD |
| GluN2A |
Multiple |
Synaptic targeting |
- cAMP/PKA: Cross-talk with CaMKII signaling
- PDE: Regulation of cAMP levels
- PP1/PP2A: Dephosphorylation and inactivation
- NMDA receptor: Bidirectional regulation
- AMPA receptor: Trafficking and function
CaMKII is essential for LTP induction:
- Glutamate binds NMDA receptors
- Ca²⁺ enters postsynaptic spine
- Calcium-calmodulin activates CaMKII
- CaMKII phosphorylates AMPA receptors
- More AMPA receptors inserted into membrane
- Synaptic strength increased
Evidence:
- CaMKII T286A knock-in mice show LTP deficits
- CaMKII inhibitors block LTP induction
- Constitutively active CaMKII induces LTP without tetanization
CaMKII also participates in LTD:
- Required for certain forms of NMDA-dependent LTD
- Dephosphorylation of substrates reverses LTP
- Balance between kinases and phosphatases determines direction
- Synaptic scaling: CaMKII regulates AMPA receptor insertion
- Metaplasticity: Alters threshold for LTP/LTD
- Spine morphology: Controls spine size and stability
CaMKII dysregulation is implicated in AD:
- Tau phosphorylation: CaMKII can phosphorylate tau at multiple sites
- Amyloid-β effects: Aβ reduces CaMKII activity
- Memory deficits: CaMKII inhibition contributes to cognitive decline
- Synaptic loss: CaMKII dysfunction leads to synaptic impairment
Therapeutic Implications:
- CaMKII activators under investigation for AD
- Gene therapy approaches to restore CaMKII function
- Small molecule activators in development
- Dopaminergic signaling: CaMKII modulates dopamine receptor function
- L-DOPA-induced dyskinesias: CaMKII overactivity contributes
- Alpha-synuclein effects: CaMKII may be affected by α-syn aggregation
Therapeutic Targeting:
- CaMKII inhibitors for dyskinesia management
- Dopamine-CaMKII signaling modulation
- Gain-of-function mutations: Cause epileptic encephalopathy
- Network hyperexcitability: CaMKII dysregulation contributes
- Therapeutic potential: CaMKII inhibitors for epilepsy
- Transcriptional dysregulation: CaMKII affects gene expression
- Synaptic dysfunction: Loss of CaMKII localization
- Therapeutic approaches: Restoration of CaMKII function
¶ Stroke and Brain Injury
- Excitotoxicity: CaMKII activation contributes to damage
- Ischemic preconditioning: CaMKII activation can be protective
- Therapeutic window: Timing of intervention critical
| Approach |
Stage |
Description |
| CaMKII inhibitors |
Preclinical |
For epilepsy, dyskinesias |
| CaMKII activators |
Preclinical |
For AD, memory enhancement |
| Peptide inhibitors |
Research |
Targeting specific isoforms |
| Gene therapy |
Research |
Viral delivery of modulators |
- Broad expression makes specificity difficult
- Chronic vs acute effects differ
- Multiple isoforms have distinct functions
- Blood-brain barrier penetration needed
- CaMKIIα KO mice: LTP deficit, learning impairment
- Conditional KOs: Region-specific insights
- Constitutively active CaMKII: Enhanced LTP
- Dominant negative: Block plasticity
- Human mutations: Epilepsy models
- AD models: CaMKII signaling deficits
- PD models: Dyskinesia mechanisms
- Epilepsy models: Gain-of-function studies
- Not established as diagnostic biomarker
- CSF/blood levels under investigation
- Synaptic health indicator
- Postmortem brain studies
- Animal model biochemistry
- Cellular models
- Western blotting for expression
- Immunohistochemistry for localization
- Co-immunoprecipitation for interactions
- Whole-cell patch clamp
- Field EPSP recordings
- LTP/LTD induction protocols
- Two-photon microscopy
- FRET for CaMKII activation
- Super-resolution microscopy
- Lisman J, et al. The molecular basis of CaMKII function in synaptic plasticity. Nat Rev Neurosci. 2002;3(3):175-190. PMID:11963137
- Lisman JE, Zhabotinsky AM. A model of CaMKII activation. Neuron. 2001;31(3):451-460. PMID:11516402
- Miller SG, Kennedy MB. Regulation of brain type II CaM kinase by autophosphorylation. Cell. 1986;44(6):861-870. PMID:3006917
- Hudmon A, Schulman H. Structure-function of the multifunctional Ca²⁺/calmodulin-dependent protein kinase II. Biochem J. 2002;364(Pt 3):593-611. PMID:11931630
- Takemoto-Kimura S, et al. Regulation of dendritogenesis via CaMKII. Cell Calcium. 2017;63:42-47. PMID:28119011
- Colbran RJ, Brown AM. Calcium/calmodulin-dependent protein kinase II and synaptic plasticity. Curr Opin Neurobiol. 2004;14(3):318-327. PMID:15194108
The study of Camkii Alpha Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Lisman J, et al. (2002). The molecular basis of CaMKII function in synaptic plasticity. Nat Rev Neurosci. 3(3):175-190. PMID:11963137
- Lisman JE, Zhabotinsky AM. (2001). A model of CaMKII activation. Neuron. 31(3):451-460. PMID:11516402
- Miller SG, Kennedy MB. (1986). Regulation of brain type II CaM kinase by autophosphorylation. Cell. 44(6):861-870. PMID:3006917
- Hudmon A, Schulman H. (2002). Structure-function of the multifunctional Ca²⁺/calmodulin-dependent protein kinase II. Biochem J. 364(Pt 3):593-611. PMID:11931630
- Takemoto-Kimura S, et al. (2017). Regulation of dendritogenesis via CaMKII. Cell Calcium. 63:42-47. PMID:28119011
- Colbran RJ, Brown AM. (2004). Calcium/calmodulin-dependent protein kinase II and synaptic plasticity. Curr Opin Neurobiol. 14(3):318-327. PMID:15194108